TEAS timing to aid recovery after stomach cancer surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, randomized, sham-controlled trial compares three TEAS timing strategies in adults aged 18-80 undergoing laparoscopic radical gastrectomy for stage I-III gastric cancer. Groups receive perioperative TEAS, postoperative TEAS only, or sham TEAS at all times, with all participants receiving standard pain relief and recovery care. TEAS uses a noninvasive electrical device applied to four acupoints to see if it speeds bowel function, reduces pain, and lowers analgesic needs. The study aims to determine if timing TEAS around surgery offers added benefits compared with delayed or no TEAS. Enrollment targets 300 participants across 13 hospitals in Shandong Province, China.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 18 to 80 years, both sexes
* Endoscopically and radiographically confirmed resectable stage I-III gastric cancer (AJCC 8th edition)
* Scheduled to undergo laparoscopic radical gastrectomy
* Willing to sign the informed consent form and able to comply with all study procedures

Exclusion Criteria:

* American Society of Anesthesiologists (ASA) physical status ≥ IV
* Clinical stage IV gastric cancer
* Severe hepatic, renal, cardiovascular, or cerebrovascular diseases, or uncontrolled psychiatric disorders that may affect compliance or safety assessment
* Participation in another clinical trial or receipt of any form of acupoint stimulation (acupuncture, electroacupuncture, TEAS, etc.) within 1 month prior to enrollment
* Continuous use of opioids for more than 3 months prior to enrollment, with a daily dose ≥ 30 mg oral morphine equivalent
* Implanted cardiac pacemaker or other electronic stimulation device, or skin infection/lesion at the stimulation site
* Pregnancy or lactation
* Emergency surgery due to bleeding, perforation, obstruction, etc.
* Planned epidural anesthesia for the surgery

Where it's running

• Department of Gastrointestinal Surgery, Qingdao University Affiliated Hospital
  Qingdao, Shandong, China Recruiting
• Dongying People's Hospital
  Dongying, Shandong, China Not yet recruiting
• Qingdao Municipal Hospital
  Qingdao, Shandong, China Not yet recruiting
• The Third People's Hospital of Qingdao
  Qingdao, Shandong, China Not yet recruiting
• Qingdao Central Hospital, University of Health and Rehabilitation Sciences
  Qingdao, Shandong, China Not yet recruiting
• Peking University People's Hospital Qingdao
  Qingdao, Shandong, China Not yet recruiting

Study contacts

• Study coordinator: Yi Li, MD
• Email: zhanmusi8755@163.com
• Phone: +86 186 6180 0210

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• TEAS after gastrectomy to aid recovery after laparoscopic stomach cancer surgery

  A randomized trial tests whether transcutaneous electrical acupoint stimulation (TEAS) after laparoscopic gastrectomy helps people recover faster and with less pain compared with a sham treatment.

  Recruiting at 8 sites The Affiliated Hospital of Qingdao University · Qingdao, Shandong and 7 other locations · NCT07898293

• Candonilimab with Fruquintinib and Paclitaxel Albumin-Bound as second-line treatment for advanced gastric cancer

  This phase 2 trial tests whether adding candonilimab to fruquintinib and nab-paclitaxel helps people with advanced gastric or gastroesophageal junction cancer who progressed after first-line therapy.

  Recruiting Phase 2 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07920224

• Maintenance therapy in metastatic gastric cancer: a multicenter look from Colombia

  This study reviews medical records of adults with metastatic gastric cancer in Colombia to see how patients fare after starting maintenance therapy following initial chemotherapy.

  Recruiting at 4 sites Fundación Santa Fe de Bogota · Bogotá, Bogota D.C. and 3 other locations · NCT07856212

• Anti-PD-1 with chemotherapy and intraperitoneal nab-paclitaxel for untreated advanced gastric cancer with ascites

  This study tests whether adding anti-PD-1 therapy to standard chemotherapy plus intraperitoneal nab-paclitaxel can help patients with untreated advanced gastric cancer and malignant ascites.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07855640

• Intratumoral oncolytic virus plus immune checkpoint inhibitors in metastatic colorectal, gastric, or liver cancer

  Doctors are testing whether injecting an oncolytic virus directly into tumors along with immune checkpoint drugs is safe and may help people with advanced colorectal, gastric, or liver cancer who have tried many treatments.

  Recruiting Foshan Fosun Chancheng Hospital · Guangdong, Foshan · NCT07850882

• Multimodal Prehabilitation for Gastric Cancer Patients

  This program tests whether a combined pre- and post-operative wellness plan can reduce inflammation after gastric cancer surgery in adults.

  Recruiting National University Hospital, Singapore · Singapore · NCT07839702

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.